Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study

Growth hormone treatment for childhood short stature and risk of stroke in early adulthood

(2014) A. Poidvin et al.   NEUROLOGY

Secuelas endocrinológicas en niños y adolescentes supervivientes de tumores del sistema nervioso central tras 5 años de seguimiento

(2013) M. Güemes Hidalgo et al.   ANALES DE PEDIATRIA

Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up

(2012) D S Olsson et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: Involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R)

(2012) Qiang Li et al.   JOURNAL OF CLINICAL NEUROSCIENCE

The superiority of conservative resection and adjuvant radiation for craniopharyngiomas

(2012) Adam Schoenfeld et al.   JOURNAL OF NEURO-ONCOLOGY

Craniopharyngioma: history

(2012) Garni Barkhoudarian et al.   Pituitary

Editorial

(2010) Edward R. Laws et al.   Journal of Neurosurgery-Pediatrics

Growth Hormone Therapy and the Risk of Tumor Recurrence after Brain Tumor Treatment in Children

(2010) Tilman R. Rohrer et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships

(2010) Gabriel Zada et al.   Neurosurgical Focus

Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

(2008) N Barabutis et al.   BRITISH JOURNAL OF CANCER